GE HealthCare Technologies Inc. reported its financial results for the first quarter of 2026, revealing total revenues of $5.131 billion, a 7.4% increase from $4.777 billion in the same period last year. The growth was driven by a 7.3% rise in product sales, totaling $3.345 billion, and a 7.5% increase in service sales, which reached $1.786 billion. However, net income attributable to GE HealthCare decreased to $389 million, down from $564 million in the prior year, resulting in earnings per share of $0.85 compared to $1.23 in the same quarter of 2025.
The company's operating income also saw a decline, falling to $515 million from $629 million, primarily due to increased costs associated with products and services. The cost of products sold rose by $320 million, attributed to inflation and tariffs, while service costs increased by $69 million. Total operating expenses increased to $1.462 billion from $1.383 billion, reflecting higher selling, general, and administrative expenses, as well as research and development costs.
In terms of strategic developments, GE HealthCare completed the acquisition of Intelerad for approximately $2.297 billion in cash on March 18, 2026. This acquisition is expected to enhance the company's capabilities in medical imaging software and digital enterprise workflow solutions. Additionally, the company announced a restructuring of its segments, combining Imaging and Advanced Visualization Solutions into a new segment called Advanced Imaging Solutions, effective from the second quarter of 2026.
Operationally, GE HealthCare reported a decrease in revenues from its Patient Care Solutions segment, which fell by 6.5% to $704 million, while the Pharmaceutical Diagnostics segment grew by 21.7% to $770 million, bolstered by the acquisition of Nihon Medi-Physics. The company also noted a decline in revenues from the China region, which decreased by 4.4% to $567 million, reflecting ongoing market pressures. As of March 31, 2026, GE HealthCare's total assets stood at $37.125 billion, with cash and cash equivalents decreasing to $2.285 billion from $4.512 billion at the end of 2025.
Looking ahead, GE HealthCare anticipates continued challenges from global trade dynamics, including tariffs and geopolitical tensions, which may impact its financial performance. The company is focused on mitigating these risks while leveraging its recent acquisitions to drive growth in its core segments.
About GE HealthCare Technologies Inc.
GE Healthcare Technologies Inc. is a global provider of medical imaging, diagnostic, and patient monitoring equipment, along with digital and AI-enabled healthcare solutions. Its core segments include Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Serving healthcare providers worldwide, the company focuses on precision medicine, clinical decision support, and improving patient outcomes through innovative technology, comprehensive services, and a broad product portfolio.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.